Sunday, April 20, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

937 POSTS 0 COMMENTS
Hapbee
Telehealth

2021 Breakthrough Wearable Tech: Overview on Hapbee (HAPB, HAPBF) and its...

Editor / Curator -
Hapbee
Telehealth

Interview: Scott Donnell from Hapbee (HAPB, HAPBF) on Wall Street Reporter.

Editor / Curator -
2020 Watch List

Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to...

Editor / Curator -
Emulate Therapeutics
All News

EMulate Therapeutics to Participate in the Venture Summit – Virtual Connect...

Editor / Curator -
All News

Wall Street Pounces on Hydroponics.

Editor / Curator -
Internet News

Another Look at the Snowflake (SNOW) Mega IPO.

Editor / Curator -
Citius
Biotech News

Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise...

Editor / Curator -
Stem Cells

Video: Mel Gibson Stem Cell Testimonial.

Editor / Curator -
CB Scientific
Telehealth

Philips (PHG) Completes the Acquisition of BioTelemetry, Inc.

Editor / Curator -
Precious Metals

Silver Alert. “Press the Pedal to the Metal.”

Editor / Curator -
1...525354...94Page 53 of 94

Latest article

Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC

All News Editor / Curator -
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.